ECR Presentation Opportunities

This year’s conference will showcase the world-leading dementia research taking place across Scotland. We are also delighted to provide researchers and external organisations the platform to present your work to our delegates.

Even at this virtual conference, we will facilitate opportunity for you to interact and have conversations with conference attendees.

Please see the opportunities below, for more information get in touch at sdrc@alzscot.org or call  0141 410 0104

Oral Presentations for ECRs

At the SDRC Conference, we always want to promote the research of ECRs. In addition to posters, we have limited availability for early career researchers to present a 10 minute presentation as part of our afternoon ECR session.

Presentations will be booked on a first come first serve basis.

If you would like to express an interest in presenting at the Conference, email SDRC@alzscot.org or call 0141 410 0104

Opportunities to express interest in doing a presentation will close 7th June 2021.

Join the SDRC

SDRC members are the first to find out about our latest news, events and opportunities. Join for free today

Read more SDRC Latest

The launch of the SDRC Annual Report 2019/20

The SDRC Annual Report 2019/20, launched on Monday 20th April, outlines what is new in dementia and brain health research in Scotland in the past 12 months. Once again, we are able to show the truly amazing quantity, quality and diversity of research happening...

National Workshops- Patient Public Involvement

NHS Research Scotland (NRS) has funded a small bid from the Universities of Edinburgh, Aberdeen, Dundee and Glasgow to run some Patient Public Involvement (PPI) Workshops. The idea of the workshops is to have a collective dialogue about how we progress PPI in...

Take part in a research study: Remote Cognitive Testing Survey

The University of Oxford are looking for volunteers from Scotland to take part in a survey about the Impact of COVID-19 on cognitive testing  The Translational Neuropsychology Lab at the University of Oxford, are investigating the impacts of COVID-19 UK lockdown on...

Edinburgh Dementia Prevention Summer School 2022

Edinburgh Dementia Prevention are hosting a brain health summer school on Monday 26 September - Thursday 29 September 2022, at St Leonard's Hall, Edinburgh. It is is a 4-day interactive course designed principally for trainee and qualified clinicians, nurses and...

The launch of the SDRC Annual Report 2020/21

The SDRC Annual Report 2020/21, launched at the SDRC Annual Conference 2021 on Wednesday 16th June. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. Of course, it heavily features the impact COVID has...

Announcement of the Brain Health Alliance for Research Challenge

The SDRC are excited to be part of a new collaborative research alliance, supported by the Scottish Funding Council.  The Scottish Brain Health Alliance for Research Challenge (ARC) is a project that will receive up to £600,000 to create multi-disciplinary,...

Neuroprogressive and Dementia Research Network Conference 2022

This year's Neuroprogressive and Dementia Network (from NHS Research Scotland) Annual Conference will be day focused on those most impacted by research outcomes, and an opportunity to learn from their experiences to improve the research landscape. It will bring...

Call for new members: Scottish Cognitive Ageing Network

The Scottish Cognitive Ageing Network (SCAN) was established in 2022, aimed at formalising and building on cross-institutional links in cognitive ageing research across Scotland. The inaugural meeting took place at the University of Strathclyde in May, with a second...

Treating dementia, what’s next and how do we get there?

On the 21st September 2021, World Alzheimer's Day, Alzheimer Scotland held their annual conference. It was a virtual event which was attended by people with dementia, carers, practitioners and other members of the public from all over Scotland.  In the afternoon...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...